Aptahem participates in scientific conferences that are relevant for research areas such as intensive care, haematology and others related to the syndrome sepsis.
- Poster presented at the conference Intensive Care & Emergency Medicine (ISICEM) 24-27 March 2020:
“A Novel Protein-binding RNA Aptamer, Apta-1, Emerges as a New Therapeutic Tool to Combat Sepsis“
- Article in Nature Biopharma Dealmakers, June 2018:
“Mining parasite evolution to create inflammatory disease drugs“